Omkar Speciality Chemicals has reported results for first quarter ended June 30, 2012.
The company has registered a rise of 29.60% in its net profit at Rs 5.21 crore for the quarter under review as compared to Rs 4.02 crore for the same quarter in the previous year. The total income from operation of the company has increased by 18.21% at Rs 50.31 crore for Q1FY13 as compared Rs 42.56 crore for the corresponding quarter previous year.
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of speciality chemicals viz., selenium compounds, iodine compounds, molybdenum compounds etc. and pharma intermediates viz., Potassium Iodate, Bismuth Ammonium Citrate, Bromoform etc.